Lipocine, Inc. (LPCN)
2.24
-0.02
(-0.88%)
USD |
NASDAQ |
May 29, 16:00
2.24
0.00 (0.00%)
After-Hours: 20:00
Lipocine EPS Diluted (Quarterly) : -0.5404 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Verrica Pharmaceuticals, Inc. | -0.4544 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.672M |
| Revenue (Quarterly) | 0.1194M |
| Total Expenses (Quarterly) | 3.791M |
| Enterprise Value | -6.097M |
| Gross Profit Margin (Quarterly) | 87.60% |
| Profit Margin (Quarterly) | -3.08K% |
| Earnings Yield | -87.37% |
| Normalized Earnings Yield | -87.37 |